Skip to main content
SpringerLink
Log in

Endoscopic Management of Obesity

  • Chapter
  • First Online:
Nutrition, Weight, and Digestive Health

  • 717 Accesses

Abstract

Although hypocaloric diet and exercise remain the cornerstones of weight loss management, procedural options are important augmentative therapies in individuals with higher BMIs and weight loss goals. Bariatric surgical options are effective, but invasive, carrying inherent surgical risk. Newer endoscopic approaches have been developed including space-occupying devices such as intragastric balloons, aspiration systems, small bowel devices, and endoscopic plication and suturing techniques. The following is a review of endoscopic management of obesity highlighting currently approved devices and investigational products.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Muniraj T, Day LW, Teigen LM, Ho EY, Sultan S, Davitkov P, et al. AGA clinical practice guidelines on intragastric balloons in the management of obesity. Gastroenterology. 2021;160(5):1799–808. https://doi.org/10.1053/j.gastro.2021.03.003.

    Article  PubMed  Google Scholar 

  2. Lopez-Nava G, Bautista-Castaño I, Acosta A, Bazerbachi F, Vargas EJ, Rizk M, et al. Utility of the office-based gastric emptying breath test (GEBT) in lieu of gastric scintigraphy to measure physiological response to the single fluid-filled intragastric balloon. Gastroenterolgy. 2018;154(6):S-1053. https://doi.org/10.1016/S0016-5085(18)33524-8.

    Article  Google Scholar 

  3. Gomez V, Woodman G, Abu Dayyeh BK. Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy: results of a prospective study. Obesity (Silver Spring). 2016;24(9):1849–53. https://doi.org/10.1002/oby.21555. Epub 2016/07/29. PubMed PMID: 27465076.

    Article  Google Scholar 

  4. Abu Dayyeh BK, Eaton LL, Woodman G, Fusco M, Shayani V, Billy HT, et al. 444 A randomized, multi-center study to evaluate the safety and effectiveness of an intragastric balloon as an adjunct to a behavioral modification program, in comparison with a behavioral modification program alone in the weight management of obese subjects. Gastrointest Endosc. 2015;81(5, Supplement):AB147. https://doi.org/10.1016/j.gie.2015.03.1235.

    Article  Google Scholar 

  5. Vargas EJ, Pesta CM, Bali A, Ibegbu E, Bazerbachi F, Moore RL, et al. Single fluid-filled intragastric balloon safe and effective for inducing weight loss in a real-world population. Clin Gastroenterol Hepatol. 2018;16(7):1073–80.e1. Epub 2018/02/10. https://doi.org/10.1016/j.cgh.2018.01.046.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, Sullivan S, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–38.e5. Epub 2015/08/02. https://doi.org/10.1016/j.gie.2015.03.1964.

    Article  PubMed  Google Scholar 

  7. Ponce J, Woodman G, Swain J, Wilson E, English W, Ikramuddin S, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11(4):874–81. https://doi.org/10.1016/j.soard.2014.12.006. Epub 2015/04/15. PubMed PMID: 25868829.

    Article  PubMed  Google Scholar 

  8. Agnihotri A, Xie A, Bartalos C, Kushnir V, Sullivan S, Islam S, et al. Real-world safety and efficacy of fluid-filled dual intragastric balloon for weight loss. Clin Gastroenterol Hepatol. 2018;16(7):1081–8.e1. https://doi.org/10.1016/j.cgh.2018.02.026. Epub 2018/02/27. PubMed PMID: 29481969.

    Article  PubMed  Google Scholar 

  9. Mion F, Ibrahim M, Marjoux S, Ponchon T, Dugardeyn S, Roman S, et al. Swallowable Obalon gastric balloons as an aid for weight loss: a pilot feasibility study. Obes Surg. 2013;23(5):730–3. https://doi.org/10.1007/s11695-013-0927-x.

    Article  PubMed  Google Scholar 

  10. Sullivan S, Swain J, Woodman G, Edmundowicz S, Hassanein T, Shayani V, et al. Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss. Surg Obes Relat Dis. 2018;14(12):1876–89. https://doi.org/10.1016/j.soard.2018.09.486.

    Article  PubMed  Google Scholar 

  11. Popov VB, Ou A, Schulman AR, Thompson CC. The impact of intragastric balloons on obesity-related co-morbidities: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112(3):429–39. Epub 2017/01/25. https://doi.org/10.1038/ajg.2016.530.

    Article  PubMed  Google Scholar 

  12. Bazerbachi F, Haffar S, Sawas T, Vargas EJ, Kaur RJ, Wang Z, et al. Fluid-filled versus gas-filled intragastric balloons as obesity interventions: a network meta-analysis of randomized trials. Obes Surg. 2018;28(9):2617–25. Epub 2018/04/18. https://doi.org/10.1007/s11695-018-3227-7.

    Article  PubMed  Google Scholar 

  13. Abu Dayyeh BK, Acosta A, Camilleri M, Mundi MS, Rajan E, Topazian MD, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017;15(1):37–43.e1. Epub 2016/01/10. https://doi.org/10.1016/j.cgh.2015.12.030.

    Article  PubMed  Google Scholar 

  14. Lopez-Nava G, Laster J, Anuradha N, Fook-Chong S, Bautista-Castano I, Asokkumar R. Endoscopic Sleeve Gastroplasty (ESG) for morbid obesity: how effective is it? Surg Endosc. Epub 2021/1/25. https://doi.org/10.1007/s00464-021-08289-1.

  15. Kumar N, Abu Dayyeh BK, Lopez-Nava Breviere G, Galvao Neto MP, Sahdala NP, Shaikh SN, et al. Endoscopic sutured gastroplasty: procedure evolution from first-in-man cases through current technique. Surg Endosc. 2018;32(4):2159–64. Epub 2017/10/28. https://doi.org/10.1007/s00464-017-5869-2.

    Article  PubMed  Google Scholar 

  16. Sartoretto A, Sui Z, Hill C, Dunlap M, Rivera AR, Khashab MA, et al. Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international multicenter study. Obes Surg. 2018;28(7):1812–21. Epub 2018/02/17. https://doi.org/10.1007/s11695-018-3135-x.

    Article  PubMed  Google Scholar 

  17. Kim SH, Chun HJ, Choi HS, Kim ES, Keum B, Jeen YT. Current status of intragastric balloon for obesity treatment. World J Gastroenterol. 2016;22(24):5495–504. Epub 2016/06/29. https://doi.org/10.3748/wjg.v22.i24.5495.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gaur S, Levy S, Mathus-Vliegen L, Chuttani R. Balancing risk and reward: a critical review of the intragastric balloon for weight loss. Gastrointest Endosc. 2015;81(6):1330–6. Epub 2015/04/19. https://doi.org/10.1016/j.gie.2015.01.054.

    Article  PubMed  Google Scholar 

  19. Hedjoudje A, Dayyeh BA, Cheskin LJ, Adam A, Neto MG, Badurdeen D, et al. Efficacy and safety of endoscopic sleeve gastroplasty: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019. Epub 2019/08/24; https://doi.org/10.1016/j.cgh.2019.08.022.

  20. Li P, Ma B, Gong S, Zhang X, Li W. Efficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis. Surg Endosc. 2019. Epub 2019/06/27; https://doi.org/10.1007/s00464-019-06889-6.

  21. Espinos JC, Turro R, Moragas G, Bronstone A, Buchwald JN, Mearin F, et al. Gastrointestinal physiological changes and their relationship to weight loss following the POSE procedure. Obes Surg. 2016;26(5):1081–9. Epub 2015/09/05. https://doi.org/10.1007/s11695-015-1863-8.

    Article  CAS  PubMed  Google Scholar 

  22. Espinos JC, Turro R, Mata A, Cruz M, da Costa M, Villa V, et al. Early experience with the incisionless operating platform (IOP) for the treatment of obesity : the primary obesity surgery endolumenal (POSE) procedure. Obes Surg. 2013;23(9):1375–83. Epub 2013/04/18. https://doi.org/10.1007/s11695-013-0937-8.

    Article  CAS  PubMed  Google Scholar 

  23. Miller K, Turro R, Greve JW, Bakker CM, Buchwald JN, Espinos JC. MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after pose (SM) vs. medical therapy. Obes Surg. 2017;27(2):310–22. Epub 2016/07/30. https://doi.org/10.1007/s11695-016-2295-9.

    Article  PubMed  Google Scholar 

  24. Lopez-Nava G, Bautista-Castano I, Jimenez A, de Grado T, Fernandez-Corbelle JP. The primary obesity surgery endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis. 2015;11(4):861–5. Epub 2015/02/24. https://doi.org/10.1016/j.soard.2014.09.026.

    Article  PubMed  Google Scholar 

  25. Singh S, Bazarbashi AN, Khan A, Chowdhry M, et al. Primary obesity surgery endoluminal (POSE) for the treatment of obesity: a systematic review and meta-analysis. Surg Endo. 2021; https://doi.org/10.1007/s00464-020-08267-z.

  26. Sullivan S, Stein R, Jonnalagadda S, Mullady D, Edmundowicz S. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology. 2013;145(6):1245–52.e1–5. Epub 2013/09/10. https://doi.org/10.1053/j.gastro.2013.08.056.

    Article  PubMed  Google Scholar 

  27. Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, et al. Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol. 2017;112(3):447–57. Epub 2016/12/07. https://doi.org/10.1038/ajg.2016.500.

    Article  PubMed  Google Scholar 

  28. Nystrom M, Machytka E, Noren E, Testoni PA, Janssen I, Turro Homedes J, et al. Aspiration therapy as a tool to treat obesity: 1- to 4-year results in a 201-patient multi-center post-market European registry study. Obes Surg. 2018;28(7):1860–8. Epub 2018/02/02. https://doi.org/10.1007/s11695-017-3096-5.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gys B, Plaeke P, Lamme B, Lafullarde T, Komen N, Beunis A, et al. Endoscopic gastric plication for morbid obesity: a systematic review and meta-analysis of published data over time. Obes Surg. 2019;29(9):3021–9. Epub 2019/06/24. https://doi.org/10.1007/s11695-019-04010-3.

    Article  PubMed  Google Scholar 

  30. Khan Z, Khan MA, Hajifathalian K, Shah S, Abdul M, Saumoy M, et al. Efficacy of endoscopic interventions for the management of obesity: a meta-analysis to compare endoscopic sleeve gastroplasty, aspire assist, and primary obesity surgery endolumenal. Obes Surg. 2019;29(7):2287–98. Epub 2019/04/15. https://doi.org/10.1007/s11695-019-03865-w.

    Article  PubMed  Google Scholar 

  31. Marinos G, Eliades C, Raman Muthusamy V, Greenway F. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study. Surg Obes Relat Dis. 2014;10(5):929–34. Epub 2014/07/30. https://doi.org/10.1016/j.soard.2014.03.005.

    Article  PubMed  Google Scholar 

  32. Rothstein RI, Woodman G, Swain J, de La Cruz N, Kushnir V, Pryor AD, et al. Transpyloric shuttle treatment improves cardiometabolic risk factors and quality of life in patients with obesity: results from a randomized, double-blind, sham-controlled trial. Gastroenterology. 2019;156(6):S-237. https://doi.org/10.1016/S0016-5085(19)37393-7.

    Article  Google Scholar 

  33. Greenway FL, Aronne LJ, Raben A, Astrup A, et al. A randomized, double-blind, placebo-controlled study of Gelesis100: a novel nonsystemic oral hydrogel for weight loss. Obesity. 2018 Nov;27(2):205–16. https://doi.org/10.1002/oby.22347.

    Article  CAS  PubMed  Google Scholar 

  34. Machytka E, Klvana P, Kornbluth A, Peikin S, Mathus-Vliegen LE, Gostout C, et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg. 2011;21(10):1499–507. Epub 2011/05/10. https://doi.org/10.1007/s11695-011-0424-z.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K. Obes Surg. 2014;24(5):813–9. Epub 2014/01/21. https://doi.org/10.1007/s11695-014-1176-3.

    Article  CAS  PubMed  Google Scholar 

  36. Machytka E, Gaur S, Chuttani R, Bojkova M, Kupka T, Buzga M, et al. Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study. Endoscopy. 2017;49(2):154–60. Epub 2016/12/13. https://doi.org/10.1055/s-0042-119296.

    Article  PubMed  Google Scholar 

  37. Alsabah S, Al Haddad E, Ekrouf S, Almulla A, Al-Subaie S, Al Kendari M. The safety and efficacy of the procedureless intragastric balloon. Surg Obes Relat Dis. 2018;14(3):311–7. Epub 2018/01/07. https://doi.org/10.1016/j.soard.2017.12.001.

    Article  PubMed  Google Scholar 

  38. Choi SJ, Choi HS. Various intragastric balloons under clinical investigation. Clin Endosc. 2018;51(5):407–15. Epub 2018/09/28. https://doi.org/10.5946/ce.2018.140.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Huberty V, Ibrahim M, Hiernaux M, Chau A, Dugardeyn S, Deviere J. Safety and feasibility of an endoluminal-suturing device for endoscopic gastric reduction (with video). Gastrointest Endosc. 2017;85(4):833–7. Epub 2016/08/27. https://doi.org/10.1016/j.gie.2016.08.007.

    Article  PubMed  Google Scholar 

  40. Lopez-Nava G, Asokkumar R, Rull A, Fernandez C, Bautista I, Dayyeh BA. Safety and feasibility of a novel endoscopic suturing device (EndoZip TM) for treatment of obesity: first-in-human study. Obes Surg. 2020; https://doi.org/10.1007/s11695-019-04370-w.

  41. Ruban A, Teare. The EndoBarrier: duodenal-jejunal bypass liner for diabetes and weight loss. Gastroenterol Res Pract. 2018;2018:7823182–9. https://doi.org/10.1155/2018/7823182.

    Article  PubMed  PubMed Central  Google Scholar 

  42. van Rijn S, Roebroek YGM, de Jonge C, Greve JWM, Bouvy ND. Effect of the EndoBarrier device: a 4-year follow-up of a multicenter randomized clinical trial. Obes Surg. 2019;29(4):1117–21. Epub 2019/01/11. https://doi.org/10.1007/s11695-018-03659-6.

    Article  PubMed  Google Scholar 

  43. Betzel B, Cooiman MI, Aarts EO, Janssen IMC, Wahab PJ, Groenen MJM, et al. Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation. Surg Endosc. 2020;34(1):209–15. Epub 2019/03/17. https://doi.org/10.1007/s00464-019-06752-8.

    Article  CAS  PubMed  Google Scholar 

  44. Rohde U, Hedback N, Gluud LL, Vilsboll T, Knop FK. Effect of the EndoBarrier gastrointestinal liner on obesity and type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2016;18(3):300–5. Epub 2015/11/06. https://doi.org/10.1111/dom.12603.

    Article  CAS  PubMed  Google Scholar 

  45. Sandler BJ, Rumbaut R, Swain CP, Torres G, Morales L, Gonzales L, et al. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg Endosc. 2015 Nov;29(11):3298–303. https://doi.org/10.1007/s00464-015-4081-5.

    Article  PubMed  Google Scholar 

  46. Gniuli D, Calcagno A, Dalla Libera L, Calvani R, Leccesi L, Caristo ME, et al. High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats. Diabetologia. 2010;53(10):2233–40. https://doi.org/10.1007/s00125-010-1830-9. Epub 2010/06/30. PubMed PMID: 20585935.

    Article  CAS  PubMed  Google Scholar 

  47. van Baar ACG, Holleman F, Crenier L, Haidry R, Magee C, Hopkins D, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one-year results from the first international, open-label, prospective, multicenter study. Gut. 2020;69(2):295–303. Epub 2019/07/25. https://doi.org/10.1136/gutjnl-2019-318349.

    Article  CAS  PubMed  Google Scholar 

  48. Rajagopalan H, Cherrington AD, Thompson CC, Kaplan LM, Rubino F, Mingrone G, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care. 2016;39(12):2254–61. Epub 2016/08/16. https://doi.org/10.2337/dc16-0383.

    Article  CAS  PubMed  Google Scholar 

  49. Machytka E, Buzga M, Zonca P, Lautz DB, Ryou M, Simonson DC, et al. Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes. Gastrointest Endosc. 2017;86(5):904–12. Epub 2017/07/19. https://doi.org/10.1016/j.gie.2017.07.009.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Russ Dolan & Pichamol Jirapinyo

  2. Gastroenterology, Obesity Medicine, Nutrition and Bariatric Endoscopist, Gut Theory Total Digestive Care, George Washington University Hospital, 1712 N St NW, Suite 101, Washington, DC, USA

    Janese Laster

Authors
  1. Russ Dolan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pichamol Jirapinyo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janese Laster
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janese Laster .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology, Weill Cornell Medical Center, New York, NY, USA

    Carolyn Newberry

  2. Gastroenterology, Obesity Medicine Nutrition and Bariatric Endoscopist Gut Theory Total Digestive Care, George Washington University Hospital, Washington, DC, USA

    Janese Laster

  3. GI Nutrition, Celiac Disease and Obesity Program, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA

    Octavia Pickett-Blakely

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dolan, R., Jirapinyo, P., Laster, J. (2022). Endoscopic Management of Obesity. In: Newberry, C., Laster, J., Pickett-Blakely, O. (eds) Nutrition, Weight, and Digestive Health. Springer, Cham. https://doi.org/10.1007/978-3-030-94953-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-94953-2_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-94952-5

  • Online ISBN: 978-3-030-94953-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation